Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

BIZARRE: 2 | Mind Blowing Facts

“This cherished model has now been refined”: Gibson’s sleek Les Paul Modern Studio brings the Modern line’s player-friendly features to a proper mahogany body and maple cap USA build – and all for under $2K

The latest take on the Les Paul Studio looks to offer some of the best bang for your buck of the whole USA-made line-up

Guitar World

“If we were told these two Les Pauls were made in completely different factories, we’d believe it”: Gibson Les Paul Modern Figured and Modern Lite review

Two new Les Pauls are added to the Modern strand of Gibson’s expanding USA guitar range with quite a specification and cost difference. Which one to go for?

Guitar World

Even as World of Warcraft nears its 20th anniversary, the MMO's executive producer promises that "the Worldsoul Saga is a foundation for our future"

Exclusive | Holly Longdale on what's next for World of Warcraft, the difficulty of WoW Classic Plus, and so much more

GamesRadar

From analysis to the latest developments in health,
read the most diverse news in one place.

“It’s a lower price point, but it’s not cheap and there’s no apologies with this guitar”: Gibson’s Les Paul Modern Lite offers a slimline take on the iconic LP – and the lowest priced all-mahogany, two-pickup build in the USA line

A new Gibson USA Les Paul (with two humbuckers) for under $1,500? We’re interested…

Guitar World

OPINION - Why don’t more of London’s public art galleries open past 5pm?

After a tough day at work, it’s nice to feed the soul with some culture, especially as the nights draw in. But even if you’ve paid a handsome fee for your Tate membership, you probably won’t be able to use it during the week. Both London Tates, Modern and Britain,…

Evening Standard

MSI Modern 15 laptop review: A capable budget laptop with a lot of compromises

Is this affordable 15.6-in notebook an ideal option for budget creativity and student life?

LiveScience

‘Crossroads’ at ICFF 2023: ‘There is room for everyone in American design’

‘At the Crossroads of American Design: Celebrating the Established and Emerging’ is a new exhibition at ICFF 2023 curated by David Rockwell and Wallpaper’s Pei-Ru Keh

Wallpaper

Read news from The Economist, FT, and more,
with one subscription

‘Beyond excited’: Head of Norway’s National Museum named new Tate Modern director

Karin Hindsbo vows to ‘continue the magnificent work being done’ at the landmark London venue as she prepares to replace Frances Morris in September

The Guardian - UK

NAMM 2023: Sterling by Music Man adds St. Vincent’s Goldie signature model to its lineup, alongside new Mariposa, Cutlass, Valentine and Albert Lee models

The 11-strong drop introduces new finishes, upgrades and an all-new Cutlass boldly dubbed “the perfect all-in-one workhorse for any modern player”

Guitar World

Column: With abortion rights under fire, guerrilla poster artist Robbie Conal hits the streets

LOS ANGELES -- It's 10 o'clock on a Friday night and almost three dozen people have gathered around a table at Canter's Deli on Fairfax to plan a mission. It's the day the U.S. Supreme Court has overturned Roe v. Wade, in a decision that cites a 17th century witch…

Los Angeles Times

Moderna Soars Following FDA Comments On COVID-19 Vaccine For Kids Under 5: What's Next?

Moderna, Inc (NASDAQ: MRNA) was spiking higher on Thursday, holding up better than the general markets, which saw the S&P 500 rally over 1% off the open before giving it all back.

Benzinga

Here's What To Watch On Moderna As The Stock Flies Higher

Moderna, Inc (NASDAQ: MRNA) was trading over 8% higher at one point on Monday morning, bouncing up within a descending channel pattern on the daily chart.

Benzinga

FDA advisory panel to discuss Covid-19 boosters: What we know so far

Pfizer and Moderna seek approval for second ‘booster’ doses as White House warns US has exhausted funding to buy more shots

The Independent UK

FDA advisory panel to discuss additional Covid-19 boosters: What we know so far

Pfizer and Moderna seek approval for second ‘booster’ doses as White House warns US has exhausted funding to buy more shots

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

FDA advisory panel to discuss additional Covid-19 boosters: What we know so far

Pfizer and Moderna seek approval for second ‘booster’ doses as White House warns US has exhausted funding to buy more shots

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Blizzard Entertainment

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.